Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Shares Issued (2016 - 2025)

Bio-Techne has reported Shares Issued over the past 17 years, most recently at $4.7 million for Q4 2025.

  • Quarterly results put Shares Issued at $4.7 million for Q4 2025, down 14.46% from a year ago — trailing twelve months through Dec 2025 was $49.3 million (down 31.39% YoY), and the annual figure for FY2025 was $51.7 million, down 15.09%.
  • Shares Issued for Q4 2025 was $4.7 million at Bio-Techne, down from $23.5 million in the prior quarter.
  • Over the last five years, Shares Issued for TECH hit a ceiling of $37.9 million in Q3 2021 and a floor of $4.4 million in Q1 2023.
  • Median Shares Issued over the past 5 years was $11.9 million (2022), compared with a mean of $14.0 million.
  • Biggest five-year swings in Shares Issued: tumbled 73.0% in 2022 and later soared 314.54% in 2024.
  • Bio-Techne's Shares Issued stood at $18.6 million in 2021, then tumbled by 73.0% to $5.0 million in 2022, then grew by 4.95% to $5.3 million in 2023, then increased by 5.0% to $5.5 million in 2024, then dropped by 14.46% to $4.7 million in 2025.
  • The last three reported values for Shares Issued were $4.7 million (Q4 2025), $23.5 million (Q3 2025), and $6.2 million (Q2 2025) per Business Quant data.